Fate Therapeutics Inc (FATE) dividend history
FATENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3024% below fair value
$1.02−0.12 (-10.53%)
Close on Nov 17, 2026Market cap $122.22MP/E –Yield –
Dividends
Fate Therapeutics has not reported a dividend
No dividend per share appears in Fate Therapeutics's annual filings since fiscal 2010.
See a number that looks wrong?